Name
Gene Therapy Breakout: Gene Therapy 101
Date & Time
Tuesday, October 18, 2022, 10:00 AM - 10:45 AM
Location Name
Melrose 3
Description
A rapidly growing number of new drugs and vaccines contain genetically modified DNA or RNA, with many new products entering Phase 3 clinical trials and some receiving FDA marketing approval.
This breakout session will provide an overview of the technology behind viral vectors, CAR-T cells, mRNA vaccines, and related advanced therapies. A brief discussion of special regulatory considerations for this research will be included.
Speakers
Learning Objectives
- Compare Gene Therapy/Gene Editing, Autologous / Allogeneic, and Ex Vivo / In Vivo approaches.
- Describe how cell and gene therapy products treat disease.
- Review examples of FDA-approved and investigational categories of cell and gene therapy products
This Module is Eligible for
ACRP CE Points, CCB Credits, CLE Credits, CME Credits, CNE Credits
ACRP CE Points
0.75